tirzepatide in uganda FDA Grants a New Indication for Obesity Management First Time Tirzepatide - Neo
Description
Early data are promising: retatrutide, a leading candidate in this class, produced 24.2% average weight loss at 48 weeks in a Phase 2 trial, exceeding results seen with current medications
It belongs to a group of hormones called incretins, which help increase insulin production
doi: 10.1001/jama.2023.24945 107 BucheitJAyersJPamulapatiLBrowningASissonEA
Feeling tired or weak on Mounjaro can happen if you are eating much less as a result of the medications appetite suppressing, not drinking enough, or losing weight quickly
.jpg?sfvrsn=f85d055_0)
How Can You Reduce Tirzepatide Side Effects
